Decreased Y397-FAK caused by BI853520 treatment occurred within 2 h and was continually reduced at least for 48 h (Fig. 2B, C), suggesting a fast inhibition of FAK in ovarian cancer cells. Here, PTK2 is linked to ovarian carcinoma.